421 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 9 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
Tissue enhanced
ACER2Alkaline ceramidase 2Enzymes
Predicted membrane proteins
Group enriched
ADGRF1Adhesion G protein-coupled receptor F1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 1.35e-5
Tissue enhanced
ANXA10Annexin A10Predicted intracellular proteins
Nucleus
Nucleoli
Vesicles
Liver cancer: 3.64e-6
Tissue enriched
ARL14ADP ribosylation factor like GTPase 14Predicted intracellular proteins
Lung cancer: 2.64e-5
Pancreatic cancer: 6.71e-4
Tissue enhanced
ATP1A4ATPase Na+/K+ transporting subunit alpha 4Enzymes
Predicted membrane proteins
Urothelial cancer: 2.20e-4
Tissue enhanced
BCL2L14BCL2 like 14Predicted intracellular proteins
CytosolTissue enhanced
C2orf88Chromosome 2 open reading frame 88Predicted intracellular proteins
Endometrial cancer: 4.97e-4
Renal cancer: 7.79e-4
Melanoma: 9.39e-4
Expressed in all
CASQ1Calsequestrin 1Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins
Transporters
Nucleoplasm
Mitochondria
Urothelial cancer: 8.93e-5
Tissue enriched
CEACAM18Carcinoembryonic antigen related cell adhesion molecule 18Predicted secreted proteins
MidbodyGroup enriched
CTSECathepsin EEnzymes
Predicted secreted proteins
Urothelial cancer: 5.26e-5
Group enriched
EPHB6EPH receptor B6Predicted intracellular proteins
Predicted membrane proteins
Nuclear specklesUrothelial cancer: 4.68e-5
Cervical cancer: 1.80e-4
Glioma: 6.96e-4
Tissue enhanced
FABP4Fatty acid binding protein 4Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Tissue enriched
HCAR3Hydroxycarboxylic acid receptor 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Cell JunctionsTissue enhanced
HS6ST3Heparan sulfate 6-O-sulfotransferase 3Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Nuclear membrane
Actin filaments
Renal cancer: 6.12e-5
Tissue enhanced
M1APMeiosis 1 associated proteinPredicted intracellular proteins
Nucleoli
Mitochondria
Tissue enhanced
MYO3BMyosin IIIBEnzymes
Predicted intracellular proteins
Group enriched
NIPAL4NIPA like domain containing 4Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Urothelial cancer: 6.82e-4
Tissue enhanced
PLA2G2APhospholipase A2 group IIAEnzymes
FDA approved drug targets
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Nucleoli
Melanoma: 1.49e-4
Tissue enhanced
REG4Regenerating family member 4Predicted secreted proteins
Group enriched
RHBGRh family B glycoprotein (gene/pseudogene)Predicted membrane proteins
Transporters
NucleoplasmUrothelial cancer: 8.06e-4
Tissue enhanced
SCNN1GSodium channel epithelial 1 gamma subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Renal cancer: 3.20e-7
Tissue enhanced
SPINK1Serine peptidase inhibitor, Kazal type 1Cancer-related genes
Disease related genes
Plasma proteins
Predicted secreted proteins
Renal cancer: 5.44e-7
Urothelial cancer: 2.15e-5
Tissue enriched
SPRR1ASmall proline rich protein 1APredicted intracellular proteins
Pancreatic cancer: 1.03e-4
Tissue enriched
SPTSSBSerine palmitoyltransferase small subunit BPredicted intracellular proteins
Predicted membrane proteins
Nuclear specklesTissue enhanced
SULT2A1Sulfotransferase family 2A member 1Enzymes
Predicted intracellular proteins
CytosolTissue enhanced
TMPRSS4Transmembrane protease, serine 4Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cytosol
Pancreatic cancer: 3.14e-4
Tissue enhanced
TP63Tumor protein p63Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Golgi apparatus
Cytosol
Breast cancer: 1.07e-4
Tissue enhanced
UPK3AUroplakin 3ADisease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nuclear membrane
Nuclear bodies
Group enriched
VSIG2V-set and immunoglobulin domain containing 2Predicted membrane proteins
NucleoplasmTissue enhanced
ABCA10ATP binding cassette subfamily A member 10Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
AC006486.9Predicted intracellular proteins
Tissue enhanced
ACKR3Atypical chemokine receptor 3Cancer-related genes
G-protein coupled receptors
Predicted membrane proteins
Vesicles
Plasma membrane
Renal cancer: 1.76e-6
Stomach cancer: 2.01e-4
Urothelial cancer: 2.93e-4
Cervical cancer: 4.64e-4
Expressed in all
ACOT11Acyl-CoA thioesterase 11Predicted intracellular proteins
CytosolRenal cancer: 3.07e-8
Colorectal cancer: 9.37e-4
Mixed
ACOXLAcyl-CoA oxidase-likePredicted intracellular proteins
Nucleoli
Cytosol
Urothelial cancer: 6.48e-4
Group enriched
ACSL5Acyl-CoA synthetase long-chain family member 5Enzymes
Plasma proteins
Predicted membrane proteins
Nucleus
Mitochondria
Endometrial cancer: 1.13e-4
Expressed in all
ACSM6Acyl-CoA synthetase medium-chain family member 6Enzymes
Predicted membrane proteins
Urothelial cancer: 7.71e-4
Tissue enhanced
ACTR3CARP3 actin-related protein 3 homolog CPredicted intracellular proteins
Tissue enriched
ADIRFAdipogenesis regulatory factorPlasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol
Tissue enhanced
AGR2Anterior gradient 2, protein disulphide isomerase family memberPredicted intracellular proteins
Predicted secreted proteins
CytosolRenal cancer: 8.79e-5
Liver cancer: 1.15e-4
Tissue enhanced
AKR1C2Aldo-keto reductase family 1 member C2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol
Group enriched
AKR1C3Aldo-keto reductase family 1 member C3Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol
Renal cancer: 1.22e-4
Liver cancer: 1.96e-4
Expressed in all
ALDH1L1Aldehyde dehydrogenase 1 family member L1Enzymes
Plasma proteins
Predicted intracellular proteins
CytosolRenal cancer: 2.42e-8
Tissue enhanced
ALOX5Arachidonate 5-lipoxygenaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
NucleoplasmRenal cancer: 1.80e-5
Urothelial cancer: 7.18e-4
Tissue enhanced
ALS2CLALS2 C-terminal likePredicted intracellular proteins
Endometrial cancer: 8.10e-4
Tissue enhanced
AMIGO2Adhesion molecule with Ig like domain 2Predicted membrane proteins
Golgi apparatus
Plasma membrane
Cytosol
Pancreatic cancer: 1.80e-4
Mixed
ANK3Ankyrin 3Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Plasma membraneRenal cancer: 8.88e-16
Expressed in all
ANKDD1AAnkyrin repeat and death domain containing 1APredicted intracellular proteins
Predicted secreted proteins
NucleoplasmMixed
ANKRD22Ankyrin repeat domain 22Predicted intracellular proteins
NucleusEndometrial cancer: 8.73e-6
Pancreatic cancer: 6.15e-4
Tissue enhanced
ANKRD65Ankyrin repeat domain 65Predicted intracellular proteins
NucleoplasmLung cancer: 1.08e-5
Tissue enhanced
Page of 9 | next »